OLQLFDO 7ULDO 3URWRFRO: +*7-0/'-070Mutual Non-Disclosure Agreement • January 19th, 2018
A Phase I/II Multicenter Open-label Dose Escalation Study of HGT-1110 Administered Intrathecally in Children with Metachromatic Leukodystrophy
